References
Okamura A, Watanabe M, Kozuki R, et al. Significance of intramural metastasis in patients with Esophageal squamous cell carcinoma: an indicator of aggressive cancer behavior. World J Surg. 2019;43(8):1997–2005.
Makino T, Yamasaki M, Tanaka K, et al. Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma. Br J Cancer. 2022;126(11):1555–62.
Moon DH, Jeon JH, Yang HC, et al. Intramural metastasis as a risk factor for recurrence in Esophageal squamous cell Carcinoma. Ann Thorac Surg. 2018;106(1):249–56.
Nishimaki T, Suzuki T, Tanaka Y, Aizawa K, Hatakeyama K, Muto T. Intramural metastases from thoracic esophageal cancer: local indicators of advanced disease. World J Surg. 1996;20(1):32–7.
Ushimaru Y, Makino T, Tanaka K, et al. Clinical significance of intramural metastasis as an independent prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13464-w.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest or financial ties to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ushimaru, Y., Makino, T. & Doki, Y. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 30, 5203–5204 (2023). https://doi.org/10.1245/s10434-023-13509-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13509-0